Drug Profile
Research programme: vasculotide - sanofi-aventis/Sunnybrook Health Sciences Centre
Alternative Names: Ang mimetic; Angiopoietin peptide mimetic; Multimeric Tie-2 agonist; Tie-2 ligandLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Sunnybrook Health Sciences Centre
- Class Antibacterials; Peptides
- Mechanism of Action Angiogenesis inducing agents; TIE-2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic wounds; Diabetic foot ulcer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-wounds in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetic-foot-ulcer in Canada
- 15 Feb 2011 Preclinical trials in Chronic wounds in Canada (unspecified route)